awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24602988-E35AAD6A-2800-48EE-8BE8-3FF5B67D8280
Q24602988-E35AAD6A-2800-48EE-8BE8-3FF5B67D8280
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24602988-E35AAD6A-2800-48EE-8BE8-3FF5B67D8280
A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder
P2860
Q24602988-E35AAD6A-2800-48EE-8BE8-3FF5B67D8280
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24602988-E35AAD6A-2800-48EE-8BE8-3FF5B67D8280
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b0f09347c6577b0ac65e319a517626ce32bcc355
P2860
Single-dose administration of MK-0657, an NR2B-selective NMDA antagonist, does not result in clinically meaningful improvement in motor function in patients with moderate Parkinson's disease.